About this trial
This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).
Eligibility criteria
Qualifiers
Women age 18-45 Infertile women who have completed an IVF cycle with PGT at the Colorado Center for Reproductive Medicine (CCRM) that have a mosaic embryo
Patients can be of any race, culture, sexual orientation or ethnicity
Patients that are willing to transfer a single embryo
Disqualifiers
Patients that do not meet the clinical requirements for an embryo transfer per clinic standards.
Patients that desire more than a single embryo transfer.
Patients that are using a gestational carrier.
Embryonic mosaic PGT results that include chromosome errors 13, 18, 21
Trial design
Treatments tested in this trial
- Transfer of mosaic embryo